Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Head and Neck cancer

Individualized Concurrent Chemotherapy for Patients with Stage III-IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy

Pengjie Ji, Qiongjiao Lu, Xiaoqiang Chen, Yuebing Chen, Xiane Peng, Zhiwei Chen, Cheng Lin, Shaojun Lin, Jingfeng Zong

Cancer Res Treat. 2023;55(4):1113-1122. Published online May 11, 2023 DOI: https://doi.org/10.4143/crt.2022.1651

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Hana Kim, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Keunchil Park, Yong Chan Ahn, Dongryul Oh, Myung-Ju Ahn

Cancer Res Treat. 2023;55(4):1104-1112. Published online May 17, 2023 DOI: https://doi.org/10.4143/crt.2023.502

Web of Science 4 Crossref 5

General

A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy

Young-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, Dong-Hoe Koo, Jung Hun Kang, Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Dae-Won Lee, Joohyuk Sohn, So Yeon Oh, Kyung Hee Lee, Su-Jin Koh, Keun Seok Lee, Chan-Kyu Kim, Ji-Yeon Kim, Jun Ho Ji, Sung-Bae Kim, Joo Young Ha, Ho Young Kim

Cancer Res Treat. 2023;55(4):1096-1103. Published online April 7, 2023 DOI: https://doi.org/10.4143/crt.2022.1565

Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients

Yoon Jin Cha, Chung Lee, Bio Joo, Kyung A Kim, Choong-kun Lee, Hyo Sup Shim

Cancer Res Treat. 2023;55(4):1087-1095. Published online June 15, 2023 DOI: https://doi.org/10.4143/crt.2023.682

Web of Science 2 Crossref 2

Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients

Wonyoung Choi, Yun-Hee Kim, Sang Myung Woo, Yebeen Yu, Mi Rim Lee, Woo Jin Lee, Jung Won Chun, Sung Hoon Sim, Heejung Chae, Hyoeun Shim, Keun Seok Lee, Sun-Young Kong

Cancer Res Treat. 2023;55(4):1077-1086. Published online June 12, 2023 DOI: https://doi.org/10.4143/crt.2022.1630

Crossref 2

Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer

Eunice Yoojin Lee, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im

Cancer Res Treat. 2023;55(4):1065-1076. Published online October 5, 2023 DOI: https://doi.org/10.4143/crt.2023.846

Web of Science 1 Crossref 1

Barriers in Oligometastasis Care in Korea: Radiation Oncologists’ Perspectives

Eui Kyu Chie, Chai Hong Rim, Won Kyung Cho, Yong Chan Ahn

Cancer Res Treat. 2023;55(4):1063-1064. Published online June 27, 2023 DOI: https://doi.org/10.4143/crt.2023.780

Web of Science 1 Crossref 1

ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group [Original]

Shinkyo Yoon, Miso Kim, Yong Sang Hong, Han Sang Kim, Seung Tae Kim, Jihun Kim, Hongseok Yun, Changhoon Yoo, Hee Kyung Ahn, Hyo Song Kim, In Hee Lee, In-Ho Kim, Inkeun Park, Jae Ho Jeong, Jaekyung Cheon, Jin Won Kim, Jina Yun, Sun Min Lim, Yongjun Cha, Se Jin Jang, Dae Young Zang, Tae Won Kim, Jin Hyoung Kang, Jee Hyun Kim

Cancer Res Treat. 2023;55(3):1061-1061. Published online April 21, 2023 DOI: https://doi.org/10.4143/crt.2021.1115.E

Right Then, Wrong Now: Early-Onset Colorectal Cancer in Korea

Aesun Shin, Kyu-Won Jung, Seung-Yong Jeong

Cancer Res Treat. 2023;55(3):1058-1060. Published online February 6, 2023 DOI: https://doi.org/10.4143/crt.2022.1612

Web of Science 1 Crossref 3

Case Report of Erdheim-Chester Disease Successfully Treated with Pegylated Interferon: A Single-Center Experience

Yujin Lim, Sang Eun Yoon, Junhun Cho, Darae Kim, Chul Won Jung

Cancer Res Treat. 2023;55(3):1053-1057. Published online January 19, 2023 DOI: https://doi.org/10.4143/crt.2022.1535

Efficacy of Olaparib in Treatment-Refractory, Metastatic Breast Cancer with Uncommon Somatic BRCA Mutations Detected in Circulating Tumor DNA

Jung-Ki Yoon, Jongseong Ahn, Sheehyun Kim, Hwang-Phil Kim, Jun-kyu Kang, Duhee Bang, Yoojoo Lim, Tae-You Kim

Cancer Res Treat. 2023;55(3):1048-1052. Published online January 31, 2023 DOI: https://doi.org/10.4143/crt.2022.1529

Web of Science 2 Crossref 2

Hematologic malignancy

Efficacy of Salvage Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Including Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review and Meta-Analysis

Jinchul Kim, Jinhyun Cho, Sang Eun Yoon, Won Seog Kim, Seok Jin Kim

Cancer Res Treat. 2023;55(3):1031-1047. Published online March 13, 2023 DOI: https://doi.org/10.4143/crt.2022.1658

Web of Science 1 Crossref 1

Clinical Impact of Drug Adherence of Tyrosine Kinase Inhibitors in Children with Ph-Positive Acute Lymphoblastic Leukemia

Jun-Xia Wang, Miao-Miao Yang, Li-Peng Liu, Hui-Min Zhang, Meng-Chuan Wang, Yu-Wen Chen, Xiao-Ying Zang, Fang Hu

Cancer Res Treat. 2023;55(3):1023-1030. Published online February 6, 2023 DOI: https://doi.org/10.4143/crt.2022.1618

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia

Seo-Yeon Ahn, TaeHyung Kim, Mihee Kim, Ga-Young Song, Sung-Hoon Jung, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, Chul Won Jung, Jun-Ho Jang, Hee Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Sung-Hyun Kim, Hyeoung-Joon Kim, Jae-Sook Ahn, Dennis Dong Hwan Kim

Cancer Res Treat. 2023;55(3):1011-1022. Published online January 26, 2023 DOI: https://doi.org/10.4143/crt.2022.1407

Web of Science 1 Crossref 3

Sarcoma

Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single-Center Study

Xin Liu, Chengcheng Gong, Jieyun Zhang, Wanjing Feng, Yanjing Guo, Youzhou Sang, Chunmeng Wang, Yong Chen, Jian Wang, Lin Yu, Xiaowei Zhang, Zhiguo Luo

Cancer Res Treat. 2023;55(3):1001-1010. Published online March 3, 2023 DOI: https://doi.org/10.4143/crt.2022.894

Pediatric cancer

Gonadal Function in Female Adolescent and Young Adult Survivors of Childhood Cancer

Hye Young Jin, Jun Ah Lee, Meerim Park, Hyeon Jin Park

Cancer Res Treat. 2023;55(3):992-1000. Published online January 31, 2023 DOI: https://doi.org/10.4143/crt.2022.1518

Gynecologic cancer

Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma

Nan Kang, Yinli Zhang, Shichao Guo, Ran Chen, Fangzhou Kong, Shuchun Wang, Mingming Yuan, Rongrong Chen, Danhua Shen, Jianliu Wang

Cancer Res Treat. 2023;55(3):978-991. Published online February 2, 2023 DOI: https://doi.org/10.4143/crt.2022.1647

Crossref 1

Genitourinary cancer

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer

Xiaochen Fei, Xinxing Du, Yiming Gong, Jiazhou Liu, Liancheng Fan, Jiayi Wang, Yanqing Wang, Yinjie Zhu, Jiahua Pan, Baijun Dong, Wei Xue

Cancer Res Treat. 2023;55(3):969-977. Published online March 2, 2023 DOI: https://doi.org/10.4143/crt.2022.1557

Web of Science 1 Crossref 1

Gastrointestinal cancer

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX

So Heun Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Sora Kang, Jae Ho Jeong, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Yejong Park, Bong Jun Kwak, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim

Cancer Res Treat. 2023;55(3):956-968. Published online February 27, 2023 DOI: https://doi.org/10.4143/crt.2022.409

Crossref 1

The Oncologic Implications of Tumor Multiplicity in Intrahepatic Cholangiocarcinoma: Its Prognostic Value Might Be Underestimated

So Jeong Yoon, Sunghae Park, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, Jinsoo Rhu, Gyu-Seong Choi, Jong Man Kim, Jae-Won Joh, In Woong Han

Cancer Res Treat. 2023;55(3):948-955. Published online February 27, 2023 DOI: https://doi.org/10.4143/crt.2023.290

Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria

Ja Kyung Yoon, Dai Hoon Han, Sunyoung Lee, Jin-Young Choi, Gi Hong Choi, Do Young Kim, Myeong-Jin Kim

Cancer Res Treat. 2023;55(3):939-947. Published online February 10, 2023 DOI: https://doi.org/10.4143/crt.2022.1645

Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer

Dae-Won Lee, Yoojoo Lim, Hwang-Phill Kim, Su Yeon Kim, Hanseong Roh, Jun-Kyu Kang, Kyung‑Hun Lee, Min Jung Kim, Seung-Bum Ryoo, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Sae-Won Han, Tae-You Kim

Cancer Res Treat. 2023;55(3):927-938. Published online March 7, 2023 DOI: https://doi.org/10.4143/crt.2023.268

Web of Science 4 Crossref 4

One-Week versus Two-Week Chemoradiotherapy Followed by Curative Surgery in Rectal Cancer: Long-Term Comparative Pooled Analysis of Two Prospective Multicenter Phase II Trials

Soo-Yoon Sung, Dae Yong Kim, Hong Seok Jang, Tae Hyun Kim, Hee Chul Park, Eui Kyu Chie, Taek-Keun Nam, Sung Hwan Kim, Jong Hoon Lee

Cancer Res Treat. 2023;55(3):918-926. Published online February 27, 2023 DOI: https://doi.org/10.4143/crt.2022.1646

Web of Science 1

Overview of the National Cancer Screening Program for Colorectal Cancer in Korea over 14 Years (2004-2017)

Bomi Park, Eun Young Her, Kyeongmin Lee, Fatima Nari, Jae Kwan Jun, Kui Son Choi, Mina Suh

Cancer Res Treat. 2023;55(3):910-917. Published online March 8, 2023 DOI: https://doi.org/10.4143/crt.2022.1432

Web of Science 1 Crossref 1

Anti–PD-L1 Antibody and/or 17β-Estradiol Treatment Induces Changes in the Gut Microbiome in MC38 Colon Tumor Model

Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jae Young Jang, Jina Choi, Ha-Na Lee

Cancer Res Treat. 2023;55(3):894-909. Published online January 9, 2023 DOI: https://doi.org/10.4143/crt.2022.1427

Web of Science 2 Crossref 3

Lung and Thoracic cancer

A Randomized Phase II Study of Irinotecan Plus Cisplatin with or without Simvastatin in Ever-Smokers with Extended Disease Small Cell Lung Cancer

Youngjoo Lee, Soo-Hyun Lee, Geon Kook Lee, Eun Jin Lim, Ji-Youn Han

Cancer Res Treat. 2023;55(3):885-893. Published online March 20, 2023 DOI: https://doi.org/10.4143/crt.2023.283

Web of Science 2 Crossref 2

Efficacy of Prophylactic Cranial Irradiation According to the Risk of Extracranial Recurrence in Limited-Stage Small Cell Lung Cancer

Tae Hoon Lee, Joo-Hyun Chung, Hong-Gyun Wu, Suzy Kim, Joo Ho Lee, Bhumsuk Keam, Jin-Soo Kim, Ki Hwan Kim, Byoung Hyuck Kim, Hak Jae Kim

Cancer Res Treat. 2023;55(3):875-884. Published online February 24, 2023 DOI: https://doi.org/10.4143/crt.2022.1583

Predictors of Post-chemoradiotherapy Pulmonary Complication in Locally Advanced Non–Small Cell Lung Cancer

Tae Hoon Lee, Byung-Hee Kang, Hak Jae Kim, Hong-Gyun Wu, Joo Ho Lee

Cancer Res Treat. 2023;55(3):865-874. Published online January 19, 2023 DOI: https://doi.org/10.4143/crt.2022.1538

Web of Science 1 Crossref 3

Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non–Small Cell Lung Cancer

Sang Hoon Lee, Eun Young Kim, Jung Min Han, Gyoonhee Han, Yoon Soo Chang

Cancer Res Treat. 2023;55(3):851-864. Published online March 20, 2023 DOI: https://doi.org/10.4143/crt.2022.1527

EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study

Weiguang Gu, Hua Zhang, Yiyu Lu, Minjing Li, Shuang Yang, Jianmiao Liang, Zhijian Ye, Zhihua Li, Minhong He, Xiaoliang Shi, Fei Wang, Dong You, Weiquan Gu, Weineng Feng

Cancer Res Treat. 2023;55(3):841-850. Published online February 13, 2023 DOI: https://doi.org/10.4143/crt.2022.1438

Crossref 3